MediPharm Labs Corp. (TSX: LABS)

MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13.09	17.98	24.15	34.11	19.91	38.63
Short-Term Investments	-	0.27	0.76	1.14	2.06	0.68
Cash & Short-Term Investments	13.09	18.25	24.9	35.25	21.97	39.31
Cash Growth	-8.01%	-26.73%	-29.36%	60.46%	-44.11%	272.78%
Accounts Receivable	6.69	5.52	12.35	15.72	27.72	26.22
Other Receivables	-	0.35	0.66	1.2	6.41	1.32
Receivables	6.69	5.87	13.01	16.92	34.14	27.54
Inventory	9.05	9.89	7.78	10.98	22.14	51.49
Prepaid Expenses	-	0.64	0.69	1.06	0.44	0.33
Other Current Assets	5.74	2	0.98	1.34	2.84	1.04
Total Current Assets	34.57	36.63	47.35	65.55	81.52	119.7
Property, Plant & Equipment	19.63	25.27	18.11	25.89	34.14	42.23
Long-Term Investments	-	-	-	-	0.19	0.19
Other Intangible Assets	0.9	1.03	0.04	0.04	0.23	-
Long-Term Deferred Tax Assets	-	-	-	-	-	0.59
Other Long-Term Assets	0.75	1	-	0.88	2.15	6.12
Total Assets	55.84	63.94	65.5	92.36	118.23	168.83
Accounts Payable	7.76	2.13	3.54	2.99	5.55	19.06
Accrued Expenses	2.38	4.91	3.67	4.15	9.25	3.14
Short-Term Debt	0.62	2.11	0.52	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	7.38	1.46
Current Portion of Leases	-	0.12	0.08	0.11	0.32	0.36
Current Income Taxes Payable	-	-	-	-	-	4.73
Current Unearned Revenue	-	0.39	0.49	1.32	1	-
Other Current Liabilities	-	1.21	1.15	0.31	0.75	0.1
Total Current Liabilities	10.76	10.86	9.46	8.88	24.25	28.85
Long-Term Debt	0.04	-	-	-	10.54	8.12
Long-Term Leases	-	0.07	0.03	0.1	0.22	0.64
Long-Term Unearned Revenue	-	-	-	0.23	-	-
Other Long-Term Liabilities	-	-	-	0	4.81	-
Total Liabilities	10.8	10.93	9.49	9.22	39.82	37.6
Common Stock	200.95	200.24	191.26	190.55	138.51	122.81
Retained Earnings	-185.7	-176.73	-163.65	-129.34	-74.54	-8.19
Comprehensive Income & Other	29.8	29.49	28.4	21.94	14.45	16.93
Total Common Equity	45.05	53.01	56.01	83.15	78.41	131.55
Minority Interest	-	-	-	-	-	-0.32
Shareholders' Equity	45.05	53.01	56.01	83.15	78.41	131.23
Total Liabilities & Equity	55.84	63.94	65.5	92.36	118.23	168.83
Total Debt	0.65	2.3	0.63	0.22	18.46	10.58
Net Cash (Debt)	12.44	15.95	24.27	35.04	3.51	28.73
Net Cash Growth	8.04%	-34.27%	-30.73%	897.86%	-87.78%	532.17%
Net Cash Per Share	0.03	0.04	0.09	0.14	0.03	0.21
Filing Date Shares Outstanding	411.07	404.05	282.16	273.94	257.95	134.72
Total Common Shares Outstanding	411.07	401.4	282.16	273.54	155.55	131.53
Working Capital	23.81	25.77	37.89	56.67	57.28	90.86
Book Value Per Share	0.11	0.13	0.20	0.30	0.50	1.00
Tangible Book Value	44.15	51.97	55.97	83.1	78.19	131.55
Tangible Book Value Per Share	0.11	0.13	0.20	0.30	0.50	1.00
Land	-	2.81	1.52	1.86	1.89	1.86
Buildings	-	27.84	20.93	24.79	25.49	18.25
Machinery	-	18.24	17.46	18.88	18.44	11.14
Construction In Progress	-	2.5	2.6	4.49	3.26	13.25
Leasehold Improvements	-	0.21	0.21	0.21	0.21	-

Source: S&P Capital IQ. Standard template. Financial Sources.